Boston Scientific Corporation (BSX): Price and Financial Metrics

Boston Scientific Corporation (BSX)

Today's Latest Price: $33.60 USD

0.05 (0.15%)

Updated Nov 27 5:00pm

Add BSX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

BSX Stock Summary

  • With a market capitalization of $48,112,561,022, Boston Scientific Corp has a greater market value than 95.57% of US stocks.
  • Price to trailing twelve month operating cash flow for BSX is currently 31.51, higher than 86.57% of US stocks with positive operating cash flow.
  • In terms of volatility of its share price, BSX is more volatile than merely 8.33% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Boston Scientific Corp are PHG, ETN, WM, ABB, and DD.
  • Visit BSX's SEC page to see the company's official filings. To visit the company's web site, go to

BSX Stock Price Chart Interactive Chart >

Price chart for BSX

BSX Price/Volume Stats

Current price $33.60 52-week high $46.62
Prev. close $33.55 52-week low $24.10
Day low $33.44 Volume 6,363,646
Day high $33.90 Avg. volume 10,735,873
50-day MA $37.10 Dividend yield N/A
200-day MA $36.81 Market Cap 48.11B

Boston Scientific Corporation (BSX) Company Bio

Boston Scientific develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. The company was founded in 1979 and is based in Marlborough, Massachusetts.

BSX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$33.60$6.21 -82%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Boston Scientific Corp. To summarize, we found that Boston Scientific Corp ranked in the 15th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Boston Scientific Corp ended up being:

  • The company's debt burden, as measured by earnings divided by interest payments, is 0.12 -- which is good for besting just 21.92% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
  • Boston Scientific Corp's effective tax rate, as measured by taxes paid relative to net income, is at 101 -- greater than 97.23% of US stocks with positive free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Boston Scientific Corp? See IDXX, TFX, FGEN, TECH, and ZBH.

BSX Latest News Stream

Event/Time News Detail
Loading, please wait...

BSX Latest Social Stream

Loading social stream, please wait...

View Full BSX Social Stream

Latest BSX News From Around the Web

Below are the latest news stories about Boston Scientific Corp that investors may wish to consider to help them evaluate BSX as an investment opportunity.

Mobile Health Market To See Record Break Revenue $230 billion By 2027 | Bayer Healthcare., Boston Scientific Corporation

According to the research report published by Allied Market Research, the global mHealth market is expected to register a CAGR of 22.3% from 2020 to 2027. The research includes changing market dynamics, top impacting factors, key investment pockets, value chain,

OpenPR | October 2, 2020

Endometrial Resection Devices Market is booming worldwide and is being examined in the latest research with the most important players: Boston Scientific Corporation, Medtronic Plc., Ethicon US, Minerva Surgical, etc.

The Global Endometrial Resection Devices Market research report published by Reports and Data provides an in-depth analysis of the Endometrial Resection Devices industry and its economic landscape for businesses that offers insightful data about profitability and development for the prominent

OpenPR | October 1, 2020

Impact of Covid-19 on Gastrointestinal Devices Market – New Business Opportunities and Investment Research Report 2027 | Covidien Ltd, Boston Scientific Corporation, Johnson & Johnson, CONMED Corporation

The global gastrointestinal devices market is forecast to reach USD 13.54 Billion by 2027, according to a new report by Reports and Data. The gastroenterology is the branch of medical science pertaining to the health of the digestive system, or the gastrointestinal

OpenPR | October 1, 2020

Pain Management Devices Market to Reflect Significant Growth During 2020–2027 | St. Jude Medical, Medtronic, Boston Scientific Corporation,, etc

Pain Management Devices Market Overview According to the newly published report by Reports and Data, the Pain Management Devices Market report presents an extensive overview of the industry scenario and gives insights into the growth opportunities in the industry during the

OpenPR | September 30, 2020

Deep Brain Stimulation Systems Market: A Well-Defined Technological Growth Map With An Impact-Analysis|NeuroPace, Boston Scientific, Fisher Wallace, SceneRay

Businesses are highly relying on the different segments covered in the Deep Brain Stimulation Systems Market research report which gives better insights to drive the business into right direction. This report also provides information regarding Deep Brain Stimulation Systems market

OpenPR | September 30, 2020

Read More 'BSX' Stories Here

BSX Price Returns

1-mo -1.96%
3-mo -18.09%
6-mo -10.50%
1-year -22.31%
3-year 27.85%
5-year 81.43%
YTD -25.70%
2019 27.96%
2018 42.56%
2017 14.61%
2016 17.30%
2015 39.17%

Continue Researching BSX

Want to see what other sources are saying about Boston Scientific Corp's financials and stock price? Try the links below:

Boston Scientific Corp (BSX) Stock Price | Nasdaq
Boston Scientific Corp (BSX) Stock Quote, History and News - Yahoo Finance
Boston Scientific Corp (BSX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8845 seconds.